Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000950170-25-034972·TCG Crossover GP I, LLC
Schedule 13G ownership disclosure
Tyra Biosciences Inc
Common Stock, par value $0.0001 per share · CUSIP: 90240B106
Event date: 2025-02-27
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- TCG Crossover GP I, LLC
Shares: 2,898,103 · Class: 5.7%
- TCG Crossover Fund I, L.P.
Shares: 2,898,103 · Class: 5.7%
- Chen Yu
Shares: 2,898,103 · Class: 5.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-034972
- Form type
- SCHEDULE 13G
- Filer
- TCG Crossover GP I, LLC
- CIK
- CIK 1839947
- Filed
- Mar 06, 2025
- Reporting period
- Feb 27, 2025
- Description
- Schedule 13G beneficial ownership